MedCap AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	302.9	272.3	227.5	170.9	127
Depreciation & Amortization	153.3	115.4	104	87.8	75.5
Other Adjustments	-118.3	-99.3	-34.2	-27	-30.8
Change in Receivables	-47	44.1	-8.3	-159.8	-36.5
Changes in Inventories	22.4	42.3	-47.2	-10.8	-16
Changes in Other Operating Activities	29.4	-14.7	-13.9	24.4	-2.9
Operating Cash Flow	342.7	360	228	85.5	116.3
Operating Cash Flow Growth	-4.81%	57.89%	166.67%	-26.48%	0.61%
Capital Expenditures	-25.7	-41.7	-22.1	-26.3	-45.3
Purchases of Intangible Assets	-36.5	-24.5	-17.2	-18	-15.6
Payments for Business Acquisitions	-330.1	-62.7	-113.1	-11.9	-4.6
Other Investing Activities	1	0.1	0.1	0.1	0.7
Investing Cash Flow	-391.3	-128.8	-152.3	-56.1	-64.8
Short-Term Debt Issued	-0.7	-15	-36.9	-2.8	0.9
Net Short-Term Debt Issued (Repaid)	-0.7	-15	-36.9	-2.8	0.9
Long-Term Debt Issued	181	0	-	120	-
Long-Term Debt Repaid	-132.1	-67	-84.6	-54.4	-66
Net Long-Term Debt Issued (Repaid)	48.9	-67	-84.6	65.6	-66
Issuance of Common Stock	28.3	35.9	-	-	1.1
Repurchase of Common Stock	-26.1	-	-	-	-
Net Common Stock Issued (Repurchased)	2.2	35.9	-	-	1.1
Other Financing Activities	1.7	-	1.8	-1.7	-
Financing Cash Flow	52.2	-46.1	-119.7	61.2	-64.1
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-3.4	-3.2	-4.1	5.9	5.7
Net Cash Flow	3.6	185.2	-43.9	90.5	-12.5
Free Cash Flow	317	318.3	205.9	59.2	71
Free Cash Flow Growth	-0.41%	54.59%	247.80%	-16.62%	-31.93%
FCF Margin	14.74%	17.15%	12.75%	5.13%	7.48%
Free Cash Flow Per Share	21.13	21.41	13.86	4.00	4.80
Levered Free Cash Flow	447.4	226.7	71.5	255.5	42.7
Unlevered Free Cash Flow	410.72	319.16	197.34	207.77	117.77

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.